1. Pischon T, Hu F, Rexrode K, Girman C, Manson J, Rimm E. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis. 2008;197:392–9.

2. Firatli E. The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. J Periodontol. 1997;68:136–40.

3. D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani A, Deanfield J. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93:3989–94.

4. Vergnes JN, Kaminski M, Lelong N, Musset AM, Sixou M, Nabet C. Maternal dental caries and pre-term birth: results from the EPIPAP study. Acta Odontol Scand. 2011.

5. Löe H. Care. D. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329–34.

6. Soell M, Hassan M, Miliauskaite A, Haïkel Y, Selimovic D. The oral cavity of elderly patients in diabetes. Diabetes Metab. 2007;33(Suppl 1):S10–8.

7. Slots J. Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol. 1986;1:48–57.

8. Doan N, Contreras A, Flynn J, Morrison J, Slots J. Proficiencies of three anaerobic culture systems for recovering periodontal pathogenic bacteria. J Clin Microbiol. 1999;37:171–4.

9. Saito T, Shimazaki Y. Metabolic disorders related to obesity and periodontal disease. Periodontol. 2007;43:254–66.

10. Hettne K, Weeber M, Laine M, Ten Cate H, Boyer S, Kors J. Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol. 2007;34:1016–24.

11. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.

12. Shoelson S, Lee J, Goldfine A. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793–801.

13. Preshaw PM, Bissett SM. Periodontitis: oral complication of diabetes. Endocrinol Metab Clin N Am. 2013;42(4):849–67. https://doi.org/10.1016/j.ecl.2013.05.012.

14. Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol 2000. 2006;40:11–28. https://doi.org/10.1111/j.1600-0757.2005.00141.x.

15. Preshaw PM. Antibiotics in the treatment of periodontitis. Dent Update. 2004;31(8):448 -50, 53-4, 56.

16. Taylor JJ, Preshaw PM. Gingival crevicular fluid and saliva. Periodontol 2000. 2016;70(1):7–10. doi:https://doi.org/10.1111/prd.12118.

17. Foster BL. On the discovery of cementum. J Periodontal Res. 2017;52(4):666–85. https://doi.org/10.1111/jre.12444.

18. de Jong T, Bakker AD, Everts V, Smit TH. The intricate anatomy of the periodontal ligament and its development: lessons for periodontal regeneration. J Periodontal Res. 2017;52(6):965–74. https://doi.org/10.1111/jre.12477.

19. Preshaw PM, Foster N, Taylor JJ. Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 2000. 2007;45:138–157. doi:https://doi.org/10.1111/j.1600-0757.2007.00221.x.

20. Tsuboi K, Hasegawa T, Hongo H, Yurimoto H, Kobayashi S. [Bone Cell Biology Assessed by Microscopic Approach. Novel insights about bone tissue by new microscopy systems]. Clin Calcium. 2015;25(10):1505–11. doi: CliCa151015051511.

21. Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015;2015:421746. https://doi.org/10.1155/2015/421746.

22. Listgarten MA, Loomer PM. Microbial identification in the management of periodontal diseases. A systematic review. Ann Periodontol. 2003;8(1):182–92. https://doi.org/10.1902/annals.2003.8.1.182.

23. Field CA, Gidley MD, Preshaw PM, Jakubovics N. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes. J Periodontal Res. 2012;47(4):470–8. https://doi.org/10.1111/j.1600-0765.2011.01455.x.

24. Preshaw PM, Walls AW, Jakubovics NS, Moynihan PJ, Jepson NJ, Loewy Z. Association of removable partial denture use with oral and systemic health. J Dent. 2011;39(11):711–9. https://doi.org/10.1016/j.jdent.2011.08.018.

25. Barksby HE, Lea SR, Preshaw PM, Taylor JJ. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol. 2007;149(2):217–25. https://doi.org/10.1111/j.1365-2249.2007.03441.x.

26. Blasco-Baque V, Garidou L, Pomie C, Escoula Q, Loubieres P, Le Gall-David S, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut. 2017;66(5):872–85. https://doi.org/10.1136/gutjnl-2015-309897.

27. Fak F, Tremaroli V, Bergstrom G, Backhed F. Oral microbiota in patients with atherosclerosis. Atherosclerosis. 2015;243(2):573–8. https://doi.org/10.1016/j.atherosclerosis.2015.10.097.

28. Krishnan K, Chen T, Paster BJ. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 2017;23(3):276–86. https://doi.org/10.1111/odi.12509.

29. Al-Shehri SS, Sweeney EL, Cowley DM, Liley HG, Ranasinghe PD, Charles BG, et al. Deep sequencing of the 16S ribosomal RNA of the neonatal oral microbiome: a comparison of breast-fed and formula-fed infants. Sci Rep. 2016;6:38309. https://doi.org/10.1038/srep38309.

30. Feres M, Teles F, Teles R, Figueiredo LC, Faveri M. The subgingival periodontal microbiota of the aging mouth. Periodontol 2000. 2016;72(1):30–53. doi:https://doi.org/10.1111/prd.12136.

31. O'Dowd LK, Durham J, McCracken GI, Preshaw PM. Patients' experiences of the impact of periodontal disease. J Clin Periodontol. 2010;37(4):334–9. https://doi.org/10.1111/j.1600-051X.2010.01545.x.

32. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973–4. https://doi.org/10.1001/jama.2015.4260.

33. Amiri AA, Maboudi A, Bahar A, Farokhfar A, Daneshvar F, Khoshgoeian HR, et al. Relationship between type 2 diabetic retinopathy and periodontal disease in Iranian adults. N Am J Med Sci. 2014;6(3):139–44. https://doi.org/10.4103/1947-2714.128476.

34. LaMonte MJ, Williams AM, Genco RJ, Andrews CA, Hovey KM, Millen AE, et al. Association between metabolic syndrome and periodontal disease measures in postmenopausal women: the Buffalo OsteoPerio study. J Periodontol. 2014;85(11):1489–501. https://doi.org/10.1902/jop.2014.140185.

35. Poplawska-Kita A, Siewko K, Szpak P, Krol B, Telejko B, Klimiuk PA, et al. Association between type 1 diabetes and periodontal health. Adv Med Sci. 2014;59(1):126–31. https://doi.org/10.1016/j.advms.2014.01.002.

36. Pranckeviciene A, Siudikiene J, Ostrauskas R, Machiulskiene V. Severity of periodontal disease in adult patients with diabetes mellitus in relation to the type of diabetes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(1):117–23. https://doi.org/10.5507/bp.2013.098.

37. Sakalauskiene J, Kubilius R, Gleiznys A, Vitkauskiene A, Ivanauskiene E, Saferis V. Relationship of clinical and microbiological variables in patients with type 1 diabetes mellitus and periodontitis. Med Sci Monit. 2014;20:1871–7. doi:https://doi.org/10.12659/MSM.890879.

38. Schjetlein AL, Jorgensen ME, Lauritzen T, Pedersen ML. Periodontal status among patients with diabetes in Nuuk. Greenland Int J Circumpolar Health. 2014;73:26093. https://doi.org/10.3402/ijch.v73.26093.

39. Ahmad A, Furuta M, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, et al. Association of periodontal status with liver abnormalities and metabolic syndrome. J Oral Sci. 2015;57(4):335–43. https://doi.org/10.2334/josnusd.57.335.

40. Alhabashneh R, Khader Y, Herra Z, Asa'ad F, Assad F. The association between periodontal disease and metabolic syndrome among outpatients with diabetes in Jordan. J Diabetes Metab Disord. 2015;14:67. https://doi.org/10.1186/s40200-015-0192-8.

41. Iwasaki M, Sato M, Minagawa K, Manz MC, Yoshihara A, Miyazaki H. Longitudinal relationship between metabolic syndrome and periodontal disease among Japanese adults aged >/=70 years: the Niigata study. J Periodontol. 2015;86(4):491–8. https://doi.org/10.1902/jop.2015.140398.

42. Lee KS, Lee SG, Kim EK, Jin HJ, Im SU, Lee HK, et al. Metabolic syndrome parameters in adolescents may be determinants for the future periodontal diseases. J Clin Periodontol. 2015;42(2):105–12. https://doi.org/10.1111/jcpe.12338.

43. Adachi K, Mishiro T, Tanaka S, Yoshikawa H, Kinoshita Y. A study on the relationship between reflux esophagitis and periodontitis. Intern Med. 2016;55(18):2523–8. https://doi.org/10.2169/internalmedicine.55.6898.

44. Chen X, Xie L, Liu Y, Chen D, Yu Q, Gan X, et al. Metabolic syndrome and periodontal disease among civilian pilots. Aerosp Med Hum Perform. 2016;87(12):1016–20. https://doi.org/10.3357/AMHP.4654.2016.

45. Corlan Puscu D, Ciuluvica RC, Anghel A, Malaescu GD, Ciursas AN, Popa GV, et al. Periodontal disease in diabetic patients - clinical and histopathological aspects. Romanian J Morphol Embryol. 2016;57(4):1323–9.

46. Furuta M, Liu A, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, et al. Tooth loss and metabolic syndrome in middle-aged Japanese adults. J Clin Periodontol. 2016;43(6):482–91. https://doi.org/10.1111/jcpe.12523.

47. Gomes-Filho IS. das Merces MC, de Santana Passos-Soares J, Seixas da Cruz S, Teixeira Ladeia AM, Trindade SC et al. severity of periodontitis and metabolic syndrome: is there an association? J Periodontol. 2016;87(4):357–66. https://doi.org/10.1902/jop.2015.150367.

48. Kaye EK, Chen N, Cabral HJ, Vokonas P, Garcia RI. Metabolic syndrome and periodontal disease progression in men. J Dent Res. 2016;95(7):822–8. https://doi.org/10.1177/0022034516641053.

49. Morita T, Yamazaki Y, Fujiharu C, Ishii T, Seto M, Nishinoue N, et al. Association between the duration of periodontitis and increased Cardiometabolic risk factors: a 9-year cohort study. Metab Syndr Relat Disord. 2016;14(10):475–82. https://doi.org/10.1089/met.2016.0018.

50. Seraphim AP, Chiba FY, Pereira RF, Mattera MS, Moimaz SA, Sumida DH. Relationship among periodontal disease, insulin resistance, salivary cortisol, and stress levels during pregnancy. Braz Dent J. 2016;27(2):123–7. https://doi.org/10.1590/0103-6440201600596.

51. Tavakoli M, Izadi M, Yaghini J, Rastegari A, Abed AM. A survey on the effects of metabolic syndrome on the periodontal indices of hemodialysis patients. Dent Res J (Isfahan). 2016;13(4):333–7.

52. Alazawi W, Bernabe E, Tai D, Janicki T, Kemos P, Samsuddin S, et al. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLoS One. 2017;12(12):e0185902. https://doi.org/10.1371/journal.pone.0185902.

53. Deshpande NC, Amrutiya MR. Obesity and oral health - is there a link? An observational study. J Indian Soc Periodontol. 2017;21(3):229–33. https://doi.org/10.4103/jisp.jisp_305_16.

54. Drazewski D, Grzymislawska M, Korybalska K, Czepulis N, Grzymislawski M, Witowski J et al. Oral Health Status of Patients with Lysosomal Storage Diseases in Poland. Int J Environ Res Public Health. 2017;14(3). doi:https://doi.org/10.3390/ijerph14030281.

55. Goulart AC, Armani F, Arap AM, Nejm T, Andrade JB, Bufarah HB, et al. Relationship between periodontal disease and cardiovascular risk factors among young and middle-aged Brazilians. Cross-sectional study Sao Paulo Med J. 2017;135(3):226–33. https://doi.org/10.1590/1516-3180.2016.0357300117.

56. Jaramillo A, Contreras A, Lafaurie GI, Duque A, Ardila CM, Duarte S, et al. Association of metabolic syndrome and chronic periodontitis in Colombians. Clin Oral Investig. 2017;21(5):1537–44. https://doi.org/10.1007/s00784-016-1942-9.

57. Kikui M, Kokubo Y, Ono T, Kida M, Kosaka T, Yamamoto M, et al. Relationship between metabolic syndrome components and periodontal disease in a Japanese general population: the Suita study. J Atheroscler Thromb. 2017;24(5):495–507. https://doi.org/10.5551/jat.33761.

58. Kitagawa M, Kurahashi T, Matsukubo T. Relationship between general health, lifestyle, Oral health, and periodontal disease in adults: a large cross-sectional study in Japan. Bull Tokyo Dent Coll. 2017;58(1):1–8. https://doi.org/10.2209/tdcpublication.2016-2100.

59. Musskopf ML, Daudt LD, Weidlich P, Gerchman F, Gross JL, Oppermann RV. Metabolic syndrome as a risk indicator for periodontal disease and tooth loss. Clin Oral Investig. 2017;21(2):675–83. https://doi.org/10.1007/s00784-016-1935-8.

60. Popescu D, Gheorghe D, Puiu I, Rica AM. Odontal-Periodontal Changes in Patients with Type 1 Diabetes. Curr Health Sci J. 2017;43(4):330–4. doi:https://doi.org/10.12865/CHSJ.43.04.07.

61. Sadeghi R, Taleghani F, Mohammadi S, Zohri Z. The effect of diabetes mellitus type I on periodontal and dental status. J Clin Diagn Res. 2017;11(7):ZC14–ZC7. https://doi.org/10.7860/JCDR/2017/25742.10153.

62. Sfasciotti GL, Marini R, Pacifici A, Ierardo G, Pacifici L, Polimeni A. Childhood overweight-obesity and periodontal diseases: is there a real correlation? Ann Stomatol (Roma). 2016;7(3):65–72. doi:https://doi.org/10.11138/ads/2016.7.3.065.

63. Song SJ, Lee SS, Han K, Park JB. Periodontitis is associated with diabetic retinopathy in non-obese adults. Endocrine. 2017;56(1):82–9. https://doi.org/10.1007/s12020-016-1215-z.

64. Vallogini G, Nobili V, Rongo R, De Rosa S, Magliarditi F, D'Anto V et al. Evaluation of the relationship between obesity, dental caries and periodontal disease in adolescents. Eur J Paediatr Dent. 2017;18(4):268–72. doi:https://doi.org/10.23804/ejpd.2017.18.04.02.

65. Coelho A, Carneiro AS, Pereira VF, Paula AP, Macedo AP, Carrilho EVP. Oral Health of Portuguese Children with Type 1 Diabetes: A Multiparametric Evaluation. J Clin Pediatr Dent. 2018;42(3):231–5. doi:https://doi.org/10.17796/1053-4628-42.3.12.

66. Dhir S, Kumar V. Are cardiovascular risk parameters and glycemic levels associated with periodontitis in type 2 diabetes patients? A clinical study. Indian Heart J. 2018;70(3):430–2. https://doi.org/10.1016/j.ihj.2017.10.002.

67. Diaz Rosas CY, Cardenas Vargas E, Castaneda-Delgado JE, Aguilera-Galaviz LA, Aceves Medina MC. Dental, periodontal and salivary conditions in diabetic children associated with metabolic control variables and nutritional plan adherence. Eur J Paediatr Dent. 2018;19(2):119–26. doi:https://doi.org/10.23804/ejpd.2018.19.02.05.

68. Kemer Dogan ES, Kirzioglu FY, Dogan B, Fentoglu O, Kale B. The effect of menopause on the relationship between hyperlipidemia and periodontal disease via salivary 8-hydroxy-2′-deoxyguanosine and myeloperoxidase levels. Acta Odontol Scand. 2018;76(2):92–7. https://doi.org/10.1080/00016357.2017.1386798.

69. Kim OS, Shin MH, Kweon SS, Lee YH, Kim OJ, Kim YJ, et al. The severity of periodontitis and metabolic syndrome in Korean population: the dong-gu study. J Periodontal Res. 2018;53(3):362–8. https://doi.org/10.1111/jre.12521.

70. Koo HS, Hong SM. Prevalence and risk factors for periodontitis among patients with metabolic syndrome. Metab Syndr Relat Disord. 2018;16(7):375–81. https://doi.org/10.1089/met.2018.0003.

71. Nascimento GG, Leite FRM, Peres KG, Demarco FF, Correa MB, Peres MA. Metabolic syndrome and periodontitis: a structural equation modeling approach. J Periodontol. 2019;90(6):655–62. https://doi.org/10.1002/JPER.18-0483.

72. Nibali L, Donos N, Terranova V, Di Pino A, Di Marca S, Ferrara V, et al. Left ventricular geometry and periodontitis in patients with the metabolic syndrome. Clin Oral Investig. 2019;23(6):2695–703. https://doi.org/10.1007/s00784-018-2667-8.

73. Pham T. The association between periodontal disease severity and metabolic syndrome in Vietnamese patients. Int J Dent Hyg. 2018;16(4):484–91. https://doi.org/10.1111/idh.12350.

74. Helenius-Hietala J, Suominen AL, Ruokonen H, Knuuttila M, Puukka P, Jula A, et al. Periodontitis is associated with incident chronic liver disease-a population-based cohort study. Liver Int. 2019;39(3):583–91. https://doi.org/10.1111/liv.13985.

75. Sakurai SI, Yamada SI, Karasawa I, Sakurai A, Kurita H. A longitudinal study on the relationship between dental health and metabolic syndrome in Japan. J Periodontol. 2019;90(7):728–46. https://doi.org/10.1002/JPER.18-0523.

76. Zhao D, Zhen Z, Pelekos G, Yiu KH, Jin L. Periodontal disease increases the risk for onset of systemic comorbidities in dental hospital attendees: an 18-year retrospective cohort study. J Periodontol. 2019;90(3):225–33. https://doi.org/10.1002/JPER.18-0224.

77. Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012;12:16. https://doi.org/10.1186/1471-230X-12-16.

78. Lamster IB, Pagan M. Periodontal disease and the metabolic syndrome. Int Dent J. 2017;67(2):67–77. https://doi.org/10.1111/idj.12264.

79. Nitta H, Katagiri S, Nagasawa T, Izumi Y, Ishikawa I, Izumiyama H, et al. The number of microvascular complications is associated with an increased risk for severity of periodontitis in type 2 diabetes patients: results of a multicenter hospital-based cross-sectional study. J Diabetes Investig. 2017;8(5):677–86. https://doi.org/10.1111/jdi.12633.

80. Albandar JM, Rams TE. Global epidemiology of periodontal diseases: an overview. Periodontology 2000. 2002;29:7–10.

81. D'Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93(10):3989–94. https://doi.org/10.1210/jc.2007-2522.

82. Vergnes JN. Treating periodontal disease may improve metabolic control in diabetics. Evidence-based dentistry. 2010;11(3):73–4. https://doi.org/10.1038/sj.ebd.6400734.

83. Borrell LN, Kunzel C, Lamster I, Lalla E. Diabetes in the dental office: using NHANES III to estimate the probability of undiagnosed disease. J Periodontal Res. 2007;42(6):559–65. https://doi.org/10.1111/j.1600-0765.2007.00983.x.

84. Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol. 2011;48(4):257–73. https://doi.org/10.1007/s00592-011-0333-6.

85. Blasco-Baque V, Kemoun P, Loubieres P, Arnal JF, Gourdy P, Serino M, et al. Impact of type 2 diabetes on the development of periodontal disease in the mouse. Bull Group Int Rech Sci Stomatol Odontol. 2011;50(2):11–2.

86. Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A et al. Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism. Mol Syst Biol. 2017;13(3):921. doi:https://doi.org/10.15252/msb.20167356.

87. Veitenhansl M, Stegner K, Hierl FX, Dieterle C, Feldmeier H, Gutt B, et al. 40th EASD annual meeting of the European Association for the Study of diabetes : Munich, Germany, 5-9 September 2004. Diabetologia. 2004;47(Suppl 1):A1–A464. https://doi.org/10.1007/BF03375463.

88. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008;87(5):1219–23.

89. Courbon G, Rinaudo-Gaujous M, Blasco-Baque V, Auger I, Caire R, Mijola L, et al. Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat. Ann Rheum Dis. 2019. https://doi.org/10.1136/annrheumdis-2018-213697.

90. Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci. 2007;12:3965–74.

91. Burcelin R, Garidou L, Pomie C. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. Semin Immunol. 2012;24(1):67–74. https://doi.org/10.1016/j.smim.2011.11.011.

92. Burcelin R. Gut microbiota and immune crosstalk in metabolic disease. Mol Metab. 2016;5(9):771–81. https://doi.org/10.1016/j.molmet.2016.05.016.

93. Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4592–8. https://doi.org/10.1073/pnas.1011383107.

94. Darré L, Vergnes J-N, Gourdy P, Sixou M. Efficacy of periodontal treatment on glycaemic control in diabetic patients: a meta-analysis of interventional studies. Diabetes Metab. 2008;34:497–506.

95. Grossi S. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol. 2001;6:138–45.

96. Miller L, Manwell M, Newbold D, Reding M, Rasheed A, Blodgett J. The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontol. 1992;63:843–8.

97. Vergnes JN, Canceill T, Vinel A, Laurencin-Dalicieux S, Maupas-Schwalm F, Blasco-Baque V, et al. The effects of periodontal treatment on diabetic patients: the DIAPERIO randomized controlled trial. J Clin Periodontol. 2018. https://doi.org/10.1111/jcpe.13003.

98. Rosier BT, Marsh PD, Mira A. Resilience of the Oral microbiota in health: mechanisms that prevent Dysbiosis. J Dent Res. 2018;97(4):371–80. https://doi.org/10.1177/0022034517742139.

99. Fang D, Shi D, Lv L, Gu S, Wu W, Chen Y, et al. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota. Sci Rep. 2017;7(1):8770. https://doi.org/10.1038/s41598-017-09395-8.

100. Wang L, Wu Y, Zhuang L, Chen X, Min H, Song S, et al. Puerarin prevents high-fat diet-induced obesity by enriching Akkermansia muciniphila in the gut microbiota of mice. PLoS One. 2019;14(6):e0218490. https://doi.org/10.1371/journal.pone.0218490.

101. Schneeberger M, Everard A, Gomez-Valades AG, Matamoros S, Ramirez S, Delzenne NM, et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5:16643. https://doi.org/10.1038/srep16643.

102. Moya-Perez A, Neef A, Sanz Y. Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice. PLoS One. 2015;10(7):e0126976. https://doi.org/10.1371/journal.pone.0126976.

103. Berridge MJ. Vitamin D deficiency and diabetes. Biochem J 2017;474(8):1321–1332. doi:https://doi.org/10.1042/BCJ20170042.

104. Cai T, Yang ZY, Nie L, Zhen JX, Deng L, Zhou Z. Association between vitamin D receptor BsmI gene polymorphism and periodontitis: a meta-analysis in a single ethnic group. Cell Mol Biol (Noisy-le-grand). 2017;63(11):1–4. doi:https://doi.org/10.14715/cmb/2017.63.11.1.

105. Ratheesh V, Subramanian S, Prakash PSG, Victor DJ. Evaluation of Association of Vitamin D Receptor Genetic Polymorphism with severe chronic periodontitis in an ethnic Tamilian population. Genet Test Mol Biomarkers. 2018;22(10):615–21. https://doi.org/10.1089/gtmb.2018.0190.

106. Murthykumar K, Arjunkumar R, Jayaseelan VP. Association of vitamin D receptor gene polymorphism (rs10735810) and chronic periodontitis. J Investig Clin Dent. 2019:e12440. doi:https://doi.org/10.1111/jicd.12440.